Skip to main content

Table 4 Association of glucose and lipid profile levels and other variables at Burayu Health Center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Variables Glucose/lipid profile levels
Gluc >110 mg/dl TG ≥ 150 mg/dl TC ≥ 200 mg/dl HDL < 40 mg/dl LDL ≥ 130 mg/dl
UOR (95% CI) UOR (95% CI) UOR (95% CI) UOR (95% CI) UOR (95% CI)
Gender (Female) 0.52(0.19-1.43) 0.62(0.36-1.10) 1.18(0.63-2.23) 1.37(0.77-2.45) 1.85(0.77-4.42)
P-value 0.208 0.097 0.608 0.289 0.167
Age ≥35years 1.52(0.56-4.12) 1.23(0.78-2.14) 2.30(1.29-4.10) 1.38(0.83-2.30) 2.57(1.23-5.35)
P-value 0.414 0.329 0.005 0.217 0.012
BMI >21.2 0.94(0.35-2.53) 1.27(0.76-2.11) 2.21(1.24-3.92) 1.78(1.07-2.98) 1.78(0.88-3.60)
P-value 0.908 0.358 0.007 0.028 0.108
CD4 + cells <200/mm3 3.21(1.18-8.73) 1.59(0.88-2.86) 0.82(0.42-1.62) 0.96(0.52-1.75) 0.57(0.23-1.44)
P-value 0.023 0.124 0.570 0.884 0.233
HAART Initiated 1.47(0.54-3.98) 1.96(1.17-3.29) 5.81(3.01-11.2) 2.62(1.55-4.44) 3.89(1.76-8.61)
P-value 0.453 0.01 <0.0001 < 0.0001 0.001
HIV duration ≥20 months 1.12(0.42-2.99) 1.19(0.72-1.98) 1.98(1.11-3.51) 1.37(0.82-2.28) 2.11(1.03-4.35)
P-value 0.828 0.500 0.020 0.231 0.042
TB infection 1.19(0.32-4.33) 1.11(0.56-2.23) 0.80(0.36-1.79) 0.68(0.33-1.42) 2.28(1.00-5.18)
P-value 0.798 0.590 0.590 0.307 0.049
  1. HAART, highly active antiretroviral therapy; Gluc, glucose; UOR, un adjusted odds ratio; CI, confidence interval; BMI, body mass index; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglyceride; p, significance level; TB, tuberculosis.